Ivory Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Ivory Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,541	Closed	-$209K	–	84
2016 Q3	$209K	Buy	4,541 +501	+12%	+$26.1K	0.01%	90
2016 Q2	$203K	Sell	4,040 -9,544	-70%	-$508K	0.01%	77
2016 Q1	$727K	Sell	13,584 -294,183	-96%	-$17.3M	0.03%	81
2015 Q4	$20.2M	Buy	+307,767	New	+$19M	0.54%	52
2014 Q2	–	Sell	-498,846	Closed	-$26.4M	–	169
2014 Q1	$26.4M	Sell	498,846 -156,613	-24%	-$7.24M	1.11%	27
2013 Q4	$26.3M	Buy	655,459 +333,312	+103%	+$13.1M	1.29%	28
2013 Q3	$12.2M	Sell	322,147 -859,271	-73%	-$33.5M	0.58%	43
2013 Q2	$46.3M	Buy	+1,181,418	New	+$46M	1.9%	12

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Ivory Investment Management's TEVA Position: Q4 2016 in Review

Ivory Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 4,541 shares — an estimated $209K sold.

Ivory Investment Management first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $46.3M in Q2 2013. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Ivory Investment Management reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Ivory Investment Management sold 4,541 Teva Pharmaceuticals shares in Q4 2016, an estimated $209K.
Ivory Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Ivory Investment Management's Teva Pharmaceuticals position peaked at $46.3M in Q2 2013.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Ivory Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.